[b]I hate to advocate drugs, alcohol, violence, or insanity to anyone, but they've always worked for me.[/b]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
May will soon be here. All will be told then. Elite and Teva, only two currently making this drug. Place your bets.
Still does not cite how the mechanism may or may not work in a neuroprotective way. This is total conjecture on a mouse model.
Where are the mice in a phase III NIH study? Not there, only humans.
Cite where this tells the reader exactly how the mechanism works. It does not because they do not know. It is pure conjecture based on what "they" think is happening, not what really IS happening.
NEXT!
Cite the literature that conveys the mechanisms that reduce the tremors in PD patients. Is it something in the way Isradipine works to block calcium or is it something else in Isradipines chemical structure that works on PD patients? That's right, cite the literature that discusses the way in which Isradipine may work to help PD patients.
There is no such literature... yet. Until May and even after, there will be theory and conjecture, but more than likely nothing concrete. Same as with T cells and the body's immune system. Wild guesses from fantastic egocentric Docs, until Dr Allison, a nobody figured it out without that Harvard medical degree.
May 29th March 29th April 1st May 1st... why not just quote the whole damn calendar?
When they come they will come. Geesus H~!
What some should really try to understand here is that not any calcium channel blocker may work for Parkinson Disease. That there may be something in the way this particular CCB, Isradipine, works to reduce the symptoms of PD and prolong the lives of those with the disease.
Will have to wait for the findings in May. Just something to keep in mind.
Naaaah didn't overlook anything. Glad I could help.
You expect Elite to make billions of dollars? Excellent....
And if Isradipine does turn out to be a positive treatment for folks with Parkinson as was mentioned sales will drive the stock price up. Sales cannot happen overnight, but demand can make sales and revenue grow at a rapid pace. Then there are the CNS drugs to come on line.
All in all, could be a nice rise in revenues in a relatively short period of time. Have seen it at my place where in one quarter demand drives the revenue made way UP.
I second that JGD~!
LMMFAO!!!
Never seen a bullshit meter pegged like that one~! LOL!
Thank you for your take on it. Very good observations IMO.
PH4RM4C3UT1C4LS wgat is your take on Lannett? My take is this, been surviving since 1942, and must have made valuable, reliable contacts since then. Good choice IMO.
My turn may be coming soon. Could not have timed it better.
Nope not even close Doc. Elite will be making more revenue than Purdue very soon, heck maybe even now~! LMAO~! So damn funny~!
Purdue ~2000 lawsuits~! Ahhhhahahahaha~!
There is reason for this push back down again. Just my opinion and my experience talking here.
Well, the FDA does have it's head up its ass at times. And for that reason many drugs not approved in the US are approved in the EU first.
Instead of saving lives the FDA often impedes the process to the point where lives are lost. Some watchdog agency... eh?
Lannett is growing. They have a facility in Philly.
This agreement was a joint agreement Elite and SunGen both agreed to.
Lannett must have something or they would not have entered into it.
Annual awards.... like S&H Green Stamps? Just kidding.... hope it is something very good.
Thought this vote was just to increase shares available.
$280 million in revenue/850 million shares OS (over what it is) = $0.33/share x PE 17
$0.33/share x PE 20
And don't forget a nice PE ratio of 17 or above in any earnings per share.
Just don't go by what you get now. Elite is not in a full blown revenue growth stage just yet. When Elite starts to generate REAL revenue there will be serious attention paid to this company and the potential here.
Potential is a key word. PE ratio will begin to be factored in at some point and as JustGoDeep pointed out it could be quite substantial. Not necessarily warranted, but PE ratio could be quite substantial.
My PE ratio of 17-20 is conservative and I will stick to an eventual PE of 20. That will be good enough IMO.
Man, sometimes I wish Lasars was still here to see this. Would have loved to get his take.
Well, gotta say good work Gman and Ama. Something to ponder as we await who it could be for the CNS drugs.
I know this is between Elite SunGen and the sales marketing partner, but does anyone have any idea of what the nominal fee is for sales and marketing? Glenmark with methadone and isradipine. Whoever it turns out to be with the CNS drugs.
Ball park it percentage wise. Thanks
NASDAQ, been going through some calculations and Isradipine could be a bigger than thought revenue maker for Elite. If Isradipine comes to be, Glenmark will take a slice, but that is it. Teva will compete, but Elite will be right there too.
CNS drugs like Adderall IR and going with a sales/marketing company that specialize in CNS drugs. Split will more than likely be 3 ways, SunGen and the larger reach than Glenmark company.
Current revenues added onto the mix.
With just this I think Elite will surprise. The addition of an ANDA approval for the $1.6 billion market CNS will be another revenue raiser.
Going to be very interesting buddy...… BTW, thanks for the PM.
Sackler family to lose it's money cow? Oh, I forgot about the Sackler's backup, Mundipharma. Now they can sell OxyContin to countries with no protections in place. So sad.....
but but but I thought Purdue had the formulation, OxyContin. And Purdue
has a lot to do with Elite. The FACT that Purdue did not acquire Elite back in the day is hysterically funny. They had the chance... now look at them. Pathetic! LOL LOL LOL
So even with Elite's revenue intake today, seems likely they will be bringing in more than Purdue. So funny!
It's funny you mention that Doc "but but but elite doesnt have a P/E because elite has NO earnings" Finally Purdue will have something in common with Elite...… no earnings after ~2000 lawsuits against them. Too funny!!! LMMFAO!!
And if the judge decides not to grant Purdue Chapter 11..... Bahhh Bye Purdue~!
David Herzberg was alarmed when he heard that Richard Sackler, former chairman of opioid giant Purdue Pharma, was listed as an inventor on a new patent for an opioid addiction treatment.
Patent No. 9861628 is for a fast-dissolving wafer containing buprenorphine, a generic drug that has been around since the 1970s. Herzberg, a historian who focuses on the opioid epidemic and the history of prescription drugs, said he fears the patent could keep prices high and make it more difficult for poor addicts to get treatment. "It's hard not to have that reaction of, like ... these vultures," said Herzberg, an associate professor at the University of Buffalo.
How's that working for Purdue? LMMFAO~!!!
Purdue and Sackler deserve to be flushed down the toilet with ~2000 lawsuits against them. Let's hope the judge says "no" on the Chapter 11
BK for Purdue.
Michael J Fox foundation just had a radio sponsored commercial about a new study they need volunteers for. Then on local news they had a person whose father has PD. He developed a device that goes into shoes. I believe it gives electrical stimulus to the leg whenever a chip in the device detects the onset of PD tremors coming. I believe this device will be on display at the conference in May.
This is going to be on interesting PD conference. MJF has done so much for PD by bringing it to the attention of people who might not otherwise have known.
PE of 17-20 is nominal and somewhat conservative. Agree.
Snupoled I don't know what the FDA will do. Gottlieb to step down, maybe he is tired of trying too.
Can FDA help Purdue? NOPE! FDA has no control over lawsuits directed at Purdue. Up to a judge now. Fly or die time for Purdue. Purdue was too greedy and threw people under the bus. Time to pay and pay they will... one way or the other.
Assuming a PE multiple of a conservative 20 I come up with something a bit different. Assuming even 1 billion OSS my estimate at a PE multiple of 17 - 20 is higher.
Bingo! Approximately every $50 million in EPS will be about $1/share at a PE multiple of 20.
A favorite subject: Purdue Pharmaceuticals
A judge to decide if Chapter 11 to be accepted. If he decides not to accept Chapter 11 Purdue will not be able to withstand the number of lawsuits. They will go belly up. Somewhere in the neighborhood of about 2000 lawsuits..... Sacklers will still have Mundi though and just like Big tobacco will move operations to tap the overseas market with their OxyContin.
Elite will still be going though. Who'd a thunk it doc? LMAO~!
mts, good post and I agree 100%. You get it.
Last I heard on NPR about a month ago Purdue was avoiding taking massive hits from lawsuits. Maybe things have changed in a short time, or maybe the pressure monetarily is getting to the point where they may declare BK
in order to avoid other expenses. Either way that family goes they still have Mundipharma. the other international arm of Purdue.
Not so much a conspiracy against SequestOx as it is a power play for something that isn't even really an ADF, just tamper resistant.
Purdue is actually doing quite well despite the lawsuit battles. AND there is always Mundipharma to fall back on. Purdue so far not phased.
OxyContin should be treated as though it was not even tamper resistant. A very cheap alternative the FDA backs to save face.